WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for LENZ

Based on 3 analysts offering 12 month price targets for Lenz Therapeutics Inc.
Min Forecast
$28.00+60.09%
Avg Forecast
$31.33+79.15%
Max Forecast
$34.00+94.4%

Should I buy or sell LENZ stock?

Based on 3 analysts offering ratings for Lenz Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LENZ stock forecasts and price targets.

LENZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-27

1 of 1

Forecast return on equity

Is LENZ forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is LENZ forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LENZ revenue forecast

What is LENZ's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$9.8M
Avg 2 year Forecast
$59.7M
Avg 3 year Forecast
$143.2M

LENZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LENZ$17.49$31.33+79.15%Strong Buy
RGLS$2.22$7.25+226.58%Buy
VXRT$0.84$2.00+137.53%Strong Buy
KPTI$1.28$5.33+316.64%Strong Buy
IMAB$1.80$8.00+344.44%Strong Buy

Lenz Therapeutics Stock Forecast FAQ

Is Lenz Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LENZ) stock is to Strong Buy LENZ stock.

Out of 3 analysts, 2 (66.67%) are recommending LENZ as a Strong Buy, 1 (33.33%) are recommending LENZ as a Buy, 0 (0%) are recommending LENZ as a Hold, 0 (0%) are recommending LENZ as a Sell, and 0 (0%) are recommending LENZ as a Strong Sell.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.

What is LENZ's revenue growth forecast for 2025-2027?

(NASDAQ: LENZ) Lenz Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Lenz Therapeutics's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast LENZ's revenue for 2025 to be $81,914,398, with the lowest LENZ revenue forecast at $33,278,244, and the highest LENZ revenue forecast at $110,150,988. On average, 2 Wall Street analysts forecast LENZ's revenue for 2026 to be $496,677,792, with the lowest LENZ revenue forecast at $469,223,240, and the highest LENZ revenue forecast at $524,132,343.

In 2027, LENZ is forecast to generate $1,191,361,135 in revenue, with the lowest revenue forecast at $1,150,595,286 and the highest revenue forecast at $1,232,126,984.

What is LENZ's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LENZ) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LENZ's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LENZ price target, the average LENZ price target is $31.33, with the highest LENZ stock price forecast at $34.00 and the lowest LENZ stock price forecast at $28.00.

On average, Wall Street analysts predict that Lenz Therapeutics's share price could reach $31.33 by Apr 15, 2025. The average Lenz Therapeutics stock price prediction forecasts a potential upside of 79.15% from the current LENZ share price of $17.49.

What is LENZ's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LENZ) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.